Arvanitis, Costas D. http://orcid.org/0000-0002-7737-1446
Ferraro, Gino B. http://orcid.org/0000-0002-1587-4259
Jain, Rakesh K. http://orcid.org/0000-0001-7571-3548
Article History
Accepted: 29 August 2019
First Online: 10 October 2019
Competing Interests
: R.K.J. received honorarium from Amgen; consultant fees from Chugai, Enlight, Ophthotech, SPARC and SynDevRx; owns equity in Enlight, Ophthotech and SynDevRx; and serves on the Boards of Trustees of Tekla Healthcare Investors, Tekla Life Sciences Investors, Tekla Healthcare Opportunities Fund and Tekla World Healthcare Fund. The other authors declare no competing interests.